Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.
Thomson
Essential Science Indicators - Special Topics  RSS feeds for the editorial Web sites of Essential Science Indicators.
All Topics Menu
Help || About || Contact

  
|  Previous Page  |
  |  Special Topics Menu  |  |  Next Page  |
  

ESI Special Topic of:
"Angiogenesis," Published August 2004

•> Search Special Topics
Angiogenesis Menu

Angiogenesis

TOP JOURNALS

  Top 20 Overall
Total cites • Number of papers • Cites per paper
|| Ranked by number of papers ||
1994-2004 (second bimonthly)

Rank     Journal Total
Cites
Number
of Papers
Cites Per
Paper
1 CIRCULATION 2645 318 8.32
2 FASEB J 1360 281 4.84
3 BLOOD 1977 211 9.37
4 CANCER RES 8790 211 41.66
5 CLIN CANCER RES 2463 176 13.99
6 INVEST OPHTHALMOL VISUAL SCI 428 138 3.1
7 LAB INVEST 1256 109 11.52
8 BRIT J CANCER 1669 100 16.69
9 GASTROENTEROLOGY 135 99 1.36
10 AMER J PATHOL 5320 92 57.83
11 INT J CANCER 1868 89 20.99
12 EUR J CANCER 1341 83 16.16
13 J AMER COLL CARDIOL 228 83 2.75
14 ANTICANCER RES 704 73 9.64
15 PROC NAT ACAD SCI USA 4759 72 66.1
16 BIOCHEM BIOPHYS RES COMMUN 1222 71 17.21
17 NATURE MED 8178 71 115.18
18 MOL BIOL CELL 39 66 0.59
19 J VASC RES 206 64 3.22
20
Top of page to menu
J PATHOL 1055 63 16.75

ESI Special Topic of:
"Angiogenesis," Published August 2004

•> Search Special Topics
Angiogenesis Menu || All Topics Menu

Help || About || Contact

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.